Summary
The therapeutic effects of vitamin D analogs, 1,24(R)-dihydroxycholecalciferol [1,24(R)(OH)2D3], 1,24(S)-dihydroxycholecalciferol [1,24(S)(OH)2D3], and 1,25-dihydroxycholecalciferol [1,25(OH)2D3] on immobilization osteoporosis were studied in rats. The right hind limb was immobilized through application of a plaster cast following the section of the sciatic nerve. The left hind limb was intact. Vitamin D analogs were orally administered for 6 weeks at dose levels of 0.02 and 0.10µg/kg/day, respectively. The mean lengths of the immobilized femurs were not significantly different from those of the intact femurs in all the experimental groups. In the immobilized femur of animals treated with 1,24(R)(OH)2D3, 0.10µg/kg, dry and ash weights were heavier and calcium and phosphorus contents greater than those in the nontreated group. Furthermore, the amount of calcified bone mass and the cortical thickness of the femurs of the immobilized limb in 1,24(R)(OH)2D3-treated animals were greater than those in the nontreated animals. Treatment with 1,25(OH)2D3 at 0.10µg/kg caused an increase of the bone mass in both immobilized and intact femurs when compared with those of the control group.
It was concluded that the administration of 1,24(R)(OH)2D3 diminished the effect of immobilization in the development of osteoporosis without any side effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albright, F., Smith, P. H., Richardson, A. M.: Postmenopausal osteoporosis, JAMA116:2465–2474, 1941
Heaney, R. P.: A unified concept of osteoporosis, Am. J. Med.39:877–880, 1965
Riggs, B. L., Jowsey, J., Kelly, P. J., Keating, F. R., Jr.: Bone remodeling in metabolic disease assessed by quantitative microradiography, Clin. Res.12:356, 1964
Riggs, B. L., Jowsey, J., Goldsmith, R. S., Kelly, P. J., Hoffman, D. L., Arnold, C. D.: Short and long-term effects of estrogen and synthetic anabolic hormone in post-menopausal osteoporosis, J. Clin. Invest.51:1659–1663, 1972
Hutchinson, T. A., Polansky, S. M., Feinstein, A. R.: Post-menopausal estrogens protect against fractures of hip and distal radius, Lancet 705–709, 1979
Heaney, R. P.: Estrogens and postmenopausal osteoporosis, Clin. Obstet. Gynecol.19:791–803, 1976
Fleisch, H., Russell, R. G. G., Simpson, B., Mühlbauer, R. C.: Prevention by a diphosphonate of immobilization “osteoporosis” in rats, Nature223:211–212, 1969
Mühlbauer, R. C., Russell, R. G. G., Williams, D. A., Fleisch, H.: The effects of diphosphonates, polyphosphates, and calcitonin on “immobilization osteoporosis” in rats, Eur. J. Clin. Invest.1:336–344, 1971
Michael, W. R., King, W. R., Fransis, M. D.: Effectiveness of diphosphonates in preventing “osteoporosis” of disuse in the rat, Clin. Orthop.78:271–276, 1971
Haas, H. G., Dambacher, M. A., Guncaga, J., Lauffenburger, T., Lämmle, B., Olah, J.: 1,25(OH)2 Vitamin D3 in osteoporosis—a pilot study, Horm. Metab. Res.11:168–171, 1979
Lindholm, T. S., Sevastikoglou, J. A., Lindgren, J. U.: Treatment of patients with senile, postmenopausal and corticosteroid-induced osteoporosis with 1α-hydroxy vitamin D3 and calcium: short and long-term effects, Clin. Endocrinol. [Suppl.]7:183–189, 1977
Lindgren, J. U., Lindholm, T. S.: Effect of 1-alphahydroxyvitamin D3 on osteoporosis in rats induced by oophorectomy, Calcif. Tissue Int.27:161–164, 1979
Orimo, H., Shiraki, M.: Clinical application of 1,24(R)-(OH)2D3. In A. W. Norman et al. (eds.): Vitamin D, Basic Research and Its Clinical Applications, pp. 1247–1255, Walter de Gruyter, Berlin, 1979
Reeve, J., Hesp, R., Hulme, P., Kanis, J. A., Klenerman, L., Meunier, P., Russel, R. G. G., Tellez-Yudilevich, M., Williams, Wootton, R.: The treatment of osteoporosis with 24,25-dihydroxycholecalciferol—a pilot study. In A. W. Norman et al. (eds.): Vitamin D, Basic Research and Its Clinical Application, pp. 119–122. Walter de Gruyter, Berlin, 1979
Nordin, B. E. C., Peacock, M., Crilly, R. G., Marshall, D. H.: Calcium absorption and plasma 1,25(OH)2D3 levels in post-menopausal osteoporosis. In A. W. Norman et al. (eds.): Vitamin D, Basic Research and Its Clinical Application, pp. 99–106. Walter de Gruyter, Berlin, 1979
Caywood, D. D., Wallace, L. J., Olson, W. G., Stevens, J. B.: Effects of 1α,25-dihydroxycholecalciferol in disuse osteoporosis in the dog: a histomorphometric study, Am. J. Vet. Res.40(1):89–91, 1979
Faccini, J. M.: Fluoride and bone, Calcif. Tissue Res.3:1–16, 1969
Lutwak, L., Wheden, G. D.: Osteoporosis. Disease-a-Month. Year Book Medical Publishers, Chicago, 1963
Goldsmith, R. S., Woodhouse, C. F., Ingbar, S. H., Segal, D.: Effect of phosphate supplements in patients with fractures, Lancet1:687–690, 1967
Orimo, H., Fujita, T., Yoshikawa, M.: Effect of calcitonin on the development of immobilization osteoporosis in rats, Endocrinol. Jpn.18(1):117–121, 1971
Friedman, J., Raisz, L. G.: Thyrocalcitonin: inhibitor of bone resorption in tissue culture, Science150:1465–1467, 1965
Wallach, S., Chausmer, A., Mittleman, R., Dimich, A.: In vivo inhibition of bone resorption by thyrocalcitonin, Endocrinology80:61–64, 1967
Miyada, D. S., Tappel, A. L.: Colorimetric determination of hydroxyproline, Anal. Chem.28:909–910, 1956
Burkhart, J. M., Jowsey, J.: Parathyroid and thyroid hormones in the development of immobilization osteoporosis, Endocrinology81:1053–1062, 1967
Ziegler, R., Bellwinkel, S., Schäfer, A., Minne, H.: European Symposium on Calcified Tissues, Hamburg, 1973
Conaway, H. H., Waite, L. C., Kenny, A. D.: Immobilization and bone mass in rats: effect of parathyroidectomy and acetazolamide, Calcif. Tissue Res.11:323–330, 1973
Lindgren, J. U.: Studies of the calcium accretion rate of bone during immobilization in intact and thyroparathyroidectomized adult rats, Calcif. Tissue Res.22:41–47, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Izawa, Y., Makita, T., Hino, S. et al. Immobilization osteoporosis and active vitamin D: Effect of active vitamin D analogs on the development of immobilization osteoporosis in rats. Calcif Tissue Int 33, 623–630 (1981). https://doi.org/10.1007/BF02409500
Issue Date:
DOI: https://doi.org/10.1007/BF02409500